menu
    • menu

    Company profile for CanSino Biologics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CanSino Biologics Inc. (CanSinoBIO, stock 6185.HK) is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Since its establishment in Tianjin, China in 2009, CanSinoBIO has experienced tremendous growth with now more than 450 e...
    CanSino Biologics Inc. (CanSinoBIO, stock 6185.HK) is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Since its establishment in Tianjin, China in 2009, CanSinoBIO has experienced tremendous growth with now more than 450 employees, one approved vaccine for Ebola virus disease (Ad5-EBOV) and 16 vaccine candidates in the product pipeline. CanSinoBIO has been successfully listed on the Main Board of Hong Kong Exchange and Clearing Limited

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CanSino BiologicsChina Flag
    Country
    Country
    China
    Address
    Address
    401-420, 4th Floor, Biomedical Park, 185 South Avenue, TEDA West District, Ti...
    Telephone
    Telephone
    022-58213600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.cansinotech.com/homes/onepage/index/44.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China's CanSino in mRNA vaccine deal with AstraZeneca
    China's CanSino in mRNA vaccine deal with AstraZeneca

    09 Aug 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cansino-mrna-vaccine-deal-with-astrazeneca-2023-08-08/

    REUTERS
    09 Aug 2023
    Share Share
    CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots
    CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots

    03 Feb 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cansino-confident-its-mrna-covid-vaccine-good-moderna-pfizer-shots-2023-02-03/

    REUTERS
    03 Feb 2023
    Share Share
    China's CanSino reports 'positive' interim data from COVID mRNA booster trial
    China's CanSino reports 'positive' interim data from COVID mRNA booster trial

    05 Jan 2023

    // Natalie Grover REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cansino-positive-interim-data-covid-mrna-vaccine-booster-trial-2023-01-05/

    Natalie Grover REUTERS
    05 Jan 2023
    Share Share
    CanSino rolls out inhalable COVID vaccine in Tianjin, Beijing
    CanSino rolls out inhalable COVID vaccine in Tianjin, Beijing

    10 Nov 2022

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/cansino-rolls-out-inhalable-covid-vaccine-in-tianjin-beijing/95421838

    HEALTH ET
    10 Nov 2022
    Share Share
    China approves inhaled vaccine as COVID-19 booster dose
    China approves inhaled vaccine as COVID-19 booster dose

    12 Sep 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/48/21027/china-approves-inhaled-vaccine-as-covid-19-booster-dose.html

    BIOSPECTRUMASIA
    12 Sep 2022
    Share Share
    World's first COVID-19 vaccine you can inhale approved in China
    World's first COVID-19 vaccine you can inhale approved in China

    06 Sep 2022

    // CNBC

    https://www.cnbctv18.com/healthcare/china-first-inhale-covid19-vaccine-booster-immunity-benefits-how-works-14651841.htm

    CNBC
    06 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search